Recent research results have shown that, in human malignant melanoma, the RAF–MEK–ERK (MAPK) and PI3K–AKT–mTOR (AKT) signaling pathways are constitutively activated via multiple mechanisms [8,9]. This evidence concerns the gene MTOR and melanoma.